Medical Cannabis for PTSD UK

Evidence Note: Evidence strength varies by condition. Chronic pain and epilepsy have the strongest clinical evidence base. Other conditions are treated based on specialist clinical judgement and emerging research. All prescriptions require specialist assessment.

Post-Traumatic Stress Disorder in the UK

Post-traumatic stress disorder (PTSD) is a serious and often debilitating psychiatric condition that develops following exposure to traumatic events. It affects an estimated 4% of UK adults at any one time, with higher rates among military veterans, emergency service personnel, and survivors of sexual violence. Core symptoms include intrusive re-experiencing (flashbacks, nightmares), hyperarousal, avoidance of trauma-related stimuli, and pervasive negative alterations in mood and cognition. NICE recommends trauma-focused CBT (TF-CBT) and EMDR as first-line treatments, but a substantial proportion of PTSD patients do not respond adequately.

The Endocannabinoid System and Trauma

The neurobiological link between the endocannabinoid system and PTSD is one of the most well-characterised in cannabinoid medicine. Post-mortem and neuroimaging studies have consistently demonstrated that PTSD is associated with reduced CB1 receptor availability in the amygdala and prefrontal cortex — the very brain regions responsible for fear memory processing and stress regulation. Exogenous cannabinoids restore tone to this depleted system. THC binds directly to CB1 receptors, reducing the consolidation and retrieval of fear memories. CBD facilitates fear extinction through 5-HT1A activation and indirect enhancement of endocannabinoid signalling.

Clinical Evidence in PTSD

A 2019 retrospective chart review published in Journal of Alternative and Complementary Medicine found that medical cannabis use was associated with a 75% reduction in PCL-5 scores in veterans, with 72% no longer meeting diagnostic criteria for PTSD at follow-up.
A randomised, placebo-controlled crossover trial demonstrated that nabilone (synthetic THC) significantly reduced nightmare frequency, sleep disruption, and general PTSD symptom severity in military veterans.
The Canadian military has approved nabilone for PTSD nightmares, and Israeli psychiatry has extensive real-world data showing large-scale benefit in PTSD populations.
UK data from the Medical Cannabis Registry shows significant improvements in PTSD symptom scores (PCL-5) and sleep quality at three and six months in patients prescribed cannabis-based medicines.

Specific Benefits Reported

Reduction in nightmare frequency and intensity — often the most immediate and dramatic effect
Improved sleep duration and quality
Reduced hyperarousal and startle response
Decreased intrusive thoughts and flashback frequency
Improved emotional regulation and reduced irritability
Better engagement in psychological therapy

Important Considerations

Medical cannabis for PTSD should be considered as one component of a comprehensive treatment plan that includes trauma-focused psychological therapy. Contraindications include a history of psychosis or schizophrenia spectrum disorder, severe cannabis use disorder, and active suicidality. A full psychiatric assessment is essential before any prescription is issued.

Frequently Asked Questions

Why is medical cannabis used for PTSD?

PTSD involves dysregulation of the fear memory and stress response systems, both heavily modulated by the endocannabinoid system. Clinical evidence suggests that cannabinoids can reduce nightmare frequency, improve sleep, dampen hyperarousal, and facilitate fear extinction.

Can I get medical cannabis prescribed for PTSD on the NHS?

NHS prescribing for PTSD remains extremely limited. Medical cannabis prescriptions for PTSD in the UK are currently initiated almost exclusively through specialist private clinics. A GMC-registered specialist will assess your full history before prescribing.

Does medical cannabis help with nightmares in PTSD?

Yes — one of the most consistent findings in the PTSD and cannabinoid literature is a reduction in nightmare frequency and severity. THC suppresses REM sleep, during which the majority of trauma nightmares occur. This is the basis for the prescription use of nabilone for PTSD nightmares in several countries.

Are there risks to using medical cannabis for PTSD?

As with all medications, medical cannabis carries risks including potential psychological dependence and interaction with other psychiatric medications. These risks are best managed within a structured, specialist-supervised prescribing programme that includes psychological therapy alongside pharmacotherapy.